Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Statement

11 Jan 2013 07:00

RNS Number : 3136V
Gleeson(M J)Group PLC
11 January 2013
 



 

11 January 2013

 

MJ GLEESON GROUP PLC

TRADING UPDATE

 

MJ Gleeson Group plc (GLE.L) is today issuing the following Trading Update ahead of its Half Year Results to 31 December 2012, which will be released on Thursday 28 February 2013.

 

Gleeson Homes

 

Gleeson Homes sold 164 private development homes during the period, an increase of 53% compared with the previous year's total of 107. With the inclusion of units sold to Housing Associations, the total for the period is 165 homes, compared to 130 in the comparable period.

 

Total sales, comprising reserved, contracted and completed homes, rose by 65% to £33.2m.

 

The Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan, has been very popular with our customers. We have recently secured an additional allocation of £2.0m of FirstBuy funding, which will provide assistance to about 170 first time buyers.

 

During the period Gleeson Homes has continued to increase its landbank of plots with the addition of 331 plots. The landbank of plots at 31 December comprises 2,099 plots owned with a further 1,530 plots conditionally purchased, which, if acquired, will increase the landbank to in excess of 3,600 plots.

 

Gleeson Strategic Land

 

Demand for green field residential land in the South of England from the major housebuilders remains strong. During the period Gleeson Strategic Land sold three sites, with a combined acreage of 13 acres.

 

Contracts were exchanged for the sale of the first phase of a 77 acre site in Thanet, in which the Group has 50% interest. The works to install the infrastructure for the whole of the site have now commenced.

 

During the period, planning permission was achieved on a 133 unit site at Grove, Oxfordshire and an 18 unit site at Hunston, West Sussex. Both sites are being marketed for sale in 2013.

 

The strategic land portfolio continues to be replenished. During the period, agreements were entered into regarding six new sites, comprising 126 acres.

 

 

 

The Group's cash balances at 31 December 2012 stood at £10.4m.

Jolyon Harrison, Chief Executive, commented:

 

"The performance in the first half of the financial year of both Gleeson Homes and Gleeson Strategic Land is encouraging, with profits expected to be significantly ahead of last year. The housing market remains challenging. The Group, however, remains on track to deliver a strong and sustained improvement in its performance."

 

 

 

Enquiries:

 

M J Gleeson Group plc

Jolyon Harrison Chief Executive Officer 0114 261 2900

Alan Martin Chief Financial Officer 01252 360 300

 

 

Notes to Editors

 

MJ Gleeson Group plc operates in the house building sector through the following business units; Gleeson Homes, which focuses on estate regeneration and housing development on brownfield land in the North of England; and Gleeson Strategic Land, which purchases options over land in the South of England with the objective of enhancing the value of the site concerned by securing residential planning permission.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDBSDBBGXG
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.